MedPath
TGA Approval

FIRAZYR icatibant (as acetate) 30 mg/3 mL injection pre-filled syringe (160313)

160313

FIRAZYR icatibant (as acetate) 30 mg/3 mL injection pre-filled syringe

Takeda Pharmaceuticals Australia Pty Ltd

September 3, 2010

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/773ebdcc12c6555f1029a40da58c1c86.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/be3e04b75a55bfb2de139c2153d8be2d.pdf

Active Ingredients

icatibant

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

FIRAZYR icatibant (as acetate) 30 mg/3 mL injection pre-filled syringe (160313) - TGA 批准文号 | MedPath